TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.14% | 78.63 | 1.2% | $618.81m | |
| AMGN | Amgen Inc. | 0.16% | 178.24 | 1.2% | $557.24m | |
| GILD | Gilead Sciences, Inc. | -0.22% | 67.38 | 0.9% | $542.96m | |
| BIIB | Biogen Inc. | 0.63% | 286.21 | 1.2% | $478.24m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.30% | 293.74 | 2.6% | $304.78m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.34% | 157.50 | 1.9% | $219.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.51% | 117.74 | 2.0% | $210.05m | |
| ILMN | Illumina, Inc. | -1.70% | 266.22 | 3.5% | $198.41m | |
| A | Agilent Technologies, Inc. | -1.50% | 63.16 | 1.5% | $196.40m | |
| NKTR | Nektar Therapeutics | -0.77% | 79.96 | 6.0% | $184.19m | |
| INCY | Incyte Corporation | 2.64% | 68.43 | 2.5% | $149.75m | |
| BMRN | BioMarin Pharmaceutical Inc. | 4.77% | 92.49 | 4.4% | $135.47m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.85% | 91.65 | 16.6% | $126.22m | |
| BLUE | Bluebird Bio, Inc. | 0.62% | 188.15 | 15.7% | $98.65m | |
| EXAS | Exact Sciences Corporation | -1.95% | 51.82 | 25.5% | $98.64m |
Company Profile
Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.